These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14068223)

  • 1. HYDROXYUREA: MECHANISM OF ACTION.
    FISHBEIN WN; CARBONE PP
    Science; 1963 Nov; 142(3595):1069-70. PubMed ID: 14068223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CLINICAL TRIALS OF HYDROXYUREA IN PATIENTS WITH CANCER AND LEUKEMIA.
    FISHBEIN WN; CARBONE PP; FREIREICH EJ; MISRA D; FREI E
    Clin Pharmacol Ther; 1964; 5():574-80. PubMed ID: 14209774
    [No Abstract]   [Full Text] [Related]  

  • 3. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: LEUKEMIA.
    SHULLENBERGER CC
    Cancer Chemother Rep; 1964 Aug; 40():49-50. PubMed ID: 14206918
    [No Abstract]   [Full Text] [Related]  

  • 4. PHASE II STUDIES OF HYDROXYUREA (NSC-32065) IN ADULTS: CLINICAL EVALUATION.
    KRAKOFF IH; SAVEL H; MURPHY ML
    Cancer Chemother Rep; 1964 Aug; 40():53-5. PubMed ID: 14206920
    [No Abstract]   [Full Text] [Related]  

  • 5. [CLINICAL KIDNEY FINDINGS IN LEUKEMIA AND THEIR CORRELATION WITH AUTOPSY RESULTS].
    HELBIG W; VOIGT KG
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1963; 81():163-84. PubMed ID: 14165086
    [No Abstract]   [Full Text] [Related]  

  • 6. [CHROMATOGRAPHIC STUDY OF THE FREE AMINO ACIDS IN THE BLOOD IN CHRONIC MYELOID LEUKEMIA].
    RONCHI F; GUACCI L; DEPASQUALE C
    Prog Med (Napoli); 1963 Aug; 19():484-7. PubMed ID: 14125617
    [No Abstract]   [Full Text] [Related]  

  • 7. UREASE CATALYSIS. II. INHIBITION OF THE ENZYME BY HYDROXYUREA, HYDROXYLAMINE, AND ACETOHYDROXAMIC ACID.
    FISHBEIN WN; CARBONE PP
    J Biol Chem; 1965 Jun; 240():2407-14. PubMed ID: 14304845
    [No Abstract]   [Full Text] [Related]  

  • 8. STUDIES OF URIC ACID BIOSYNTHESIS IN CHRONIC LEUKEMIA.
    KRAKOFF IH; BLIS ME
    Acta Unio Int Contra Cancrum; 1964; 20():1105-8. PubMed ID: 14274708
    [No Abstract]   [Full Text] [Related]  

  • 9. [ON PURINE METABOLISM IN LEUKOSES].
    STRELIUKHINA NV
    Ter Arkh; 1963 Jul; 35():100-6. PubMed ID: 14077554
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic and therapeutic effects of hydroxyurea in chronic myelogenous leukemia.
    Kennedy BJ; Yarbro JW
    Trans Assoc Am Physicians; 1965; 78():391-9. PubMed ID: 5217785
    [No Abstract]   [Full Text] [Related]  

  • 11. [ON KIDNEY FUNCTION IN LEUKEMIC PATIENTS].
    SIPOS J
    Orv Hetil; 1964 Apr; 105():731-2. PubMed ID: 14144968
    [No Abstract]   [Full Text] [Related]  

  • 12. [THE BLOOD TRYPTOPHAN CONTENT IN CHILDREN WITH DISEASES OF THE BLOOD SYSTEM].
    GRADOVA MG; SHOKINA NI
    Vopr Okhr Materin Det; 1963 Oct; 8():24-9. PubMed ID: 14123217
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical trial of hydroxyurea in chronic myelocytic leukemia.
    Baudo F; Cattaneo N; Cipriani D; De Cataldo F; Pensabene A; Tiso R
    Haematol Lat; 1967; 10(4):359-62. PubMed ID: 5243231
    [No Abstract]   [Full Text] [Related]  

  • 14. [Trial treatment of chronic myeloid leukemia with 3 new chemotherapeutic agents: dibromomannitol, hydroxyurea and desacetamidocolchicine].
    Cattan A; Schneider M; Schwarzenberg L; Amiel JJ; Schlumberger JR; Gluckman E; Mathé G
    Sem Hop; 1966 Nov; 42(49):2966-9. PubMed ID: 4292624
    [No Abstract]   [Full Text] [Related]  

  • 15. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chemotherapy of chronic myelocytic leukemia. Status of the German Multicenter Study on busulfan versus hydroxyurea versus alpha interferon, October 1897].
    Hehlmann R; Anger B; Messerer D; Zankovich R; Bergmann L; Kolb HJ; Meyer P; Essers U; Queisser U; Vaupel H
    Onkologie; 1988 Feb; 11(1):25-9. PubMed ID: 3283622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic and therapeutic effects of hydroxyurea in chronic myeloid leukemia.
    Kennedy BJ; Yarbro JW
    JAMA; 1966 Mar; 195(12):1038-43. PubMed ID: 5218042
    [No Abstract]   [Full Text] [Related]  

  • 18. Cutaneous ulcerations on hands and heels secondary to long-term hydroxyurea treatment.
    Friedrich S; Raff K; Landthaler M; Karrer S
    Eur J Dermatol; 2004; 14(5):343-6. PubMed ID: 15358575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma.
    Payne AN; Jackson WP; Salmon JA; Nicholls A; Yeadon M; Garland LG
    Agents Actions Suppl; 1991; 34():189-99. PubMed ID: 1793063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary observations on the therapy of the myeloid blast phase of chronic granulocytic leukemia with plicamycin and hydroxyurea.
    Koller CA; Miller DM
    N Engl J Med; 1986 Dec; 315(23):1433-8. PubMed ID: 2431313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.